NCT01754727View on ClinicalTrials.gov

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

CompletedOBSERVATIONAL
Enrollment

452

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Ankylosing Spondylitis
All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01754727 - Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice | Biotech Hunter | Biotech Hunter